Publications by authors named "K-H Song"

Xerosis, characterized by dry, rough skin, causes discomfort and aesthetic concerns, necessitating effective treatment. Traditional treatments often show limited efficacy, prompting the need for innovative therapies. This study highlights the efficacy of microbiome therapeutic LP51, derived from a healthy vaginal microbiome, in improving xerosis.

View Article and Find Full Text PDF

Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. Accurate risk stratification is essential for optimizing treatment strategies. A 14-gene RNA-level assay of lung cancer, which involves quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis of formalin-fixed paraffin-embedded (FFPE) tissue samples, offers a promising approach.

View Article and Find Full Text PDF
Article Synopsis
  • Neurofibrillary tangles (NFTs), linked to Alzheimer's disease (AD) neurodegeneration, consist of hyperphosphorylated tau proteins, particularly affecting memory in the hippocampus.* -
  • The study investigated the effects of AL04, a new protein treatment, on lowering hyperphosphorylated tau in a specific mouse model with human tau mutation, revealing significant decreases in tau levels and changes in autophagy-related proteins.* -
  • Findings suggest that AL04 could serve as a potential preventive and therapeutic agent for AD by promoting tau degradation and regulating relevant protein pathways.*
View Article and Find Full Text PDF

Protein abundance correlates only moderately with mRNA levels, and are modulated post-transcriptionally by a network of regulators including ribosomes, RNA-binding proteins (RBPs), and the proteasome. Here, we identified ster rotein abundance egulators (MaPRs) across ten cancer types by devising a new computational pipeline that jointly analyzed transcriptomes and proteomes from 1,305 tumor samples. We identified 232 to 1,394 MaPRs per cancer type, mediating up to 79% of post-transcriptional regulatory networks.

View Article and Find Full Text PDF
Article Synopsis
  • - The glycosylation profile of therapeutic proteins, especially sialylation, is important for their effectiveness and stability, particularly in fusion proteins used to treat angiogenic disorders.
  • - A mass spectrometry method was used to analyze sialylation levels in VEGFR-IgG fusion proteins by examining different fractions from production media, revealing varying sialylation levels.
  • - The study found that the overall sialylation levels matched the expected results from the different fractions, emphasizing the importance of LC-MS/MS-based analysis for quality control and consistency in biosimilar development.
View Article and Find Full Text PDF

Genomic profiling often fails to predict therapeutic outcomes in cancer. This failure is, in part, due to a myriad of genetic alterations and the plasticity of cancer signaling networks. Functional profiling, which ascertains signaling dynamics, is an alternative method to anticipate drug responses.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors, a type of cancer treatment, can cause serious side effects, including immune-related myocarditis (irMyocarditis), which can be fatal.
  • Researchers studied immune responses in the heart, tumor, and blood of 28 patients with irMyocarditis using advanced techniques like single-cell RNA sequencing and T-cell receptor (TCR) sequencing.
  • Their findings showed an increase in certain immune cells in the heart tissue of irMyocarditis patients and identified specific TCR clones associated with severe cases, shedding light on the disease's biology and potential biomarkers.
View Article and Find Full Text PDF
Article Synopsis
  • - The study explores the use of an oncolytic reovirus (RC402) administered orally to stimulate antitumor immunity in advanced cancers, showing no major side effects while effectively reducing tumor lesions.
  • - The orally delivered reovirus interacts with the immune system, enhancing antibody production, reshaping the gut microbiome, and promoting immune activation, though it doesn't directly infect tumors outside the gastrointestinal tract.
  • - Combining oral reovirus treatment with immune checkpoint inhibitors (like αPD-1 and αCTLA-4) significantly enhances tumor regression and establishes lasting immune memory, highlighting its potential as an effective immunotherapy approach in cancer treatment.
View Article and Find Full Text PDF

The mammalian reovirus Type 3 Dearing (T3D) is a naturally occurring oncolytic virus. We previously identified a T3D variant isolated from persistently infected cancer cells that has a premature stop codon mutation in the gene, generating a truncated σ1-attachment protein that lacks the globular head. We now report on the molecular characterization of this variant, named RP116, and assess its antitumor potential in human cancer cells and syngeneic mouse models.

View Article and Find Full Text PDF

Synthesis of valuable chemicals from CO electroreduction in acidic media is highly desirable to overcome carbonation. However, suppressing the hydrogen evolution reaction in such proton-rich environments remains a considerable challenge. The current study demonstrates the use of a hollow fiber silver penetration electrode with hierarchical micro/nanostructures to enable CO reduction to CO in strong acids via balanced coordination of CO and K/H supplies.

View Article and Find Full Text PDF
Article Synopsis
  • The androgen receptor (AR) is a key target for prostate cancer treatments due to its involvement in cancer progression, but current therapies have limitations, prompting the search for new strategies.
  • Researchers introduced a new AR degrader called UBX-390, which outperforms existing treatments like ARV-110 and ARCC-4 in lab studies on prostate cancer cells.
  • UBX-390 effectively reduces AR activity and gene expression, showing great promise for treating patients with advanced, treatment-resistant prostate cancer.
View Article and Find Full Text PDF

Zastaprazan (JP-1366), a novel potassium-competitive acid blocker, is a new drug for the treatment of erosive esophagitis. JP-1366 is highly metabolized in human, mouse, and dog hepatocytes but moderately metabolized in rat and monkey hepatocytes when estimated from the metabolic stability of this compound in hepatocyte suspension and when 18 phase I metabolites and 5 phase II metabolites [i.e.

View Article and Find Full Text PDF

The electronic structures, defect formations, defect transition levels and optical properties for V+H defect models in KDP crystals have been studied based on DFT. Lattice dynamics methods give the most reasonable compensation mechanism for V, namely compensation with the third-nearest H neighbor from V for the paraelectric (PE) phase and compensation with the fourth-nearest neighbor H from V for the ferroelectric (FE) phase. The defect formation energies indicate that the [Formula: see text] (The superscript represents the charged state, the 'x' represents neutral, ''' represents -1 charge state and '' represents +1 charge state.

View Article and Find Full Text PDF

Background And Purpose: The cerebral metabolic rate of oxygen (CMRO) is considered a robust marker of the infarct core in O-tracer-based PET. We aimed to delineate the infarct core in patients with acute ischemic stroke by using commonly used relative CBF (rCBF) < 30% and oxygen metabolism parameter of CMRO on CT perfusion in comparison with pretreatment DWI-derived infarct core volume.

Materials And Methods: Patients with acute ischemic stroke who met the inclusion criteria were recruited.

View Article and Find Full Text PDF

Background: The Murray law-based quantitative flow ratio (μFR) is an emerging technique that requires only 1 projection of coronary angiography with similar accuracy to quantitative flow ratio (QFR). However, it has not been validated for the evaluation of noninfarct-related artery (non-IRA) in acute myocardial infarction (AMI) settings. Therefore, our study aimed to evaluate the diagnostic accuracy of μFR and the safety of deferring non-IRA lesions with μFR >0.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitor (ICI) therapy has significantly advanced cancer treatment but is often complicated by immune-related adverse events like checkpoint inhibitor colitis (irColitis).
  • A study profiling around 300,000 cells from patients with irColitis uncovered key immune cell expansions and molecular changes in the colon mucosa and blood, highlighting the complexity of the condition.
  • Findings indicate that specific T cells and epithelial interactions are crucial for understanding irColitis and may lead to new therapeutic approaches for managing this side effect of ICI therapy.
View Article and Find Full Text PDF

Background: Dysregulated interleukin (IL)-17/IL-23 signalling contributes to psoriasis pathogenesis. Cedirogant is an inverse agonist of nuclear receptor ROR-gamma isoform 2 (RORyt), a key transcription factor responsible for IL-17 synthesis and a regulator of the T helper 17 cell lineage programme.

Objectives: To evaluate the efficacy and safety of cedirogant to treat moderate-to-severe psoriasis.

View Article and Find Full Text PDF

In the biotechnological industry, multicopy gene integration represents an effective strategy to maintain a high-level production of recombinant proteins and to assemble multigene biochemical pathways. In this study, we developed copper-induced in vivo gene amplification in budding yeast for multicopy gene expressions. To make copper as an effective selection pressure, we first constructed a copper-sensitive yeast strain by deleting the gene encoding a small metallothionein-like protein for copper resistance.

View Article and Find Full Text PDF

Background: Although clinical benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) in patients with complex coronary artery lesions have been observed in previous trials, the cost-effectiveness of this strategy is uncertain.

Methods: RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance vs Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) was conducted in Korea between May 2018 and May 2021. This prespecified cost-effectiveness substudy was conducted using Markov model that simulated 3 states: (1) post-PCI, (2) spontaneous myocardial infarction, and (3) death.

View Article and Find Full Text PDF

Context: Reliable and valid measures are critical in accurately assessing outcomes of advance care planning interventions (ACP) for end-of-life (EOL) decision-making.

Objectives: To develop measures of preparedness for EOL decision-making for patients with end-stage renal disease and their surrogates (an exemplar population).

Methods: In this 3-phase study, Phases 1 and 2 included a cross-discipline concept analysis of the preparedness construct, item generation for patient and surrogate scales (82 items), evaluation of content validity and readability, cognitive interviewing, and item reduction.

View Article and Find Full Text PDF

Background: The RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance Versus Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) demonstrated that intravascular imaging-guided percutaneous coronary intervention (PCI) improved clinical outcome compared with angiography-guided PCI for patients with complex coronary artery lesions. This study aims to assess whether the prognostic benefit of intravascular imaging-guided procedural optimization persists in patients undergoing PCI for left main coronary artery disease.

Methods: Of 1639 patients enrolled in the RENOVATE-COMPLEX-PCI, 192 patients with left main coronary artery disease were selected for the current prespecified substudy.

View Article and Find Full Text PDF

Background: There are limited data regarding the safety of deferral of percutaneous coronary intervention based on intravascular ultrasound (IVUS) findings. The current study sought to compare the prognosis between deferred lesions based on IVUS and fractional flow reserve (FFR)-guided treatment decision.

Methods: This study is a post hoc analysis of the FLAVOUR randomized trial (Fractional Flow Reserve and Intravascular Ultrasound for Clinical Outcomes in Patients With Intermediate Stenosis) that compared 2-year clinical outcomes between IVUS- and FFR-guided treatment decision on intermediate coronary artery lesions using predefined criteria.

View Article and Find Full Text PDF
Article Synopsis
  • - Seladelpar, a selective PPARδ agonist, shows promise in improving liver injury markers and reducing fibrosis in a mouse model of nonalcoholic steatohepatitis (NASH), both when used alone and in combination with other agents like liraglutide and selonsertib.
  • - The study demonstrated significant plasma liver function improvements and robust declines in liver steatosis and fibrosis through various treatments, highlighting the potential of combining seladelpar with different therapeutics to enhance treatment effectiveness.
  • - Gene expression analysis revealed that seladelpar promotes lipid oxidation and metabolic changes, suggesting it may work well alongside different mechanisms of action for tackling the challenges posed by NASH and liver fibrosis.
View Article and Find Full Text PDF

Tumor-infiltrating lymphocytes (TIL) have been suggested as an important prognostic marker in colorectal cancer, but assessment usually requires additional tissue processing and interpretational efforts. The aim of this study is to assess the clinical significance of artificial intelligence (AI)-powered spatial TIL analysis using only a hematoxylin and eosin (H&E)-stained whole-slide image (WSI) for the prediction of prognosis in stage II-III colon cancer treated with surgery and adjuvant therapy. In this retrospective study, we used Lunit SCOPE IO, an AI-powered H&E WSI analyzer, to assess intratumoral TIL (iTIL) and tumor-related stromal TIL (sTIL) densities from WSIs of 289 patients.

View Article and Find Full Text PDF